Quick Answer
Aclaris Therapeutics, Inc. reported Shares Outstanding of 120.50 million shares for fiscal year 2025.
Aclaris Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 120.50M | +11.7% |
| 2024 | 107.85M | +52.1% |
| 2023 | 70.89M | +6.3% |
| 2022 | 66.69M | +8.9% |
| 2021 | 61.23M | +35.7% |
| 2020 | 45.11M | +8.7% |
| 2019 | 41.49M | +0.7% |
| 2018 | 41.21M | +33.6% |
| 2017 | 30.86M | +18.4% |
| 2016 | 26.06M | +29.3% |
| 2015 | 20.16M | +638.3% |
| 2014 | 2.73M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 108.34M | +51.7% | +0.0% |
| June 30, 2025 | 108.33M | +51.9% | +0.1% |
| March 31, 2025 | 108.27M | +52.0% | +0.4% |
| December 31, 2024 | 107.85M | +52.1% | +51.0% |
| September 30, 2024 | 71.42M | +0.8% | +0.1% |
| June 30, 2024 | 71.33M | +0.8% | +0.1% |
| March 31, 2024 | 71.25M | +6.0% | +0.5% |
| December 31, 2023 | 70.89M | +6.3% | +0.1% |
- Aclaris Therapeutics, Inc. showed an increase of +11.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2014–2025 period, Aclaris Therapeutics, Inc.’s shares outstanding has grown by 4313.2% (from 2.73 million shares to 120.50 million shares).
- The most recent figure is from Aclaris Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: